Xifaxan 550 MG tablet UD 60S
Ended Awarded
- Contract number
- SPE2DB25FG8DQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,466
Award facts
- Contract value 100% obligated
- $4,466.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,466.25 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Xifaxan 550 mg tablets in unit dose packaging (60 count). This is a firm fixed-price delivery order with no set-aside designation, executed through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The contract is scheduled for completion by July 25, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs and other federal agencies including the Defense Health Agency and U.S. Coast Guard. The parent IDC represents AmerisourceBergen Drug Corp's capacity to fulfill diverse federal medical supply requirements through a flexible contracting mechanism that supports multiple therapeutic domains and customer needs across the defense and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FG8DQ?
SPE2DB25FG8DQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 24, 2025.
How much is contract SPE2DB25FG8DQ worth?
The government has obligated $4,466 on SPE2DB25FG8DQ.
Is contract SPE2DB25FG8DQ an order under another contract?
Yes. SPE2DB25FG8DQ is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FG8DQ competed?
The extent of competition for SPE2DB25FG8DQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award